Workflow
上海谊众: 上海谊众药业股份有限公司2024年年度股东大会决议公告

Meeting Overview - The shareholder meeting of Shanghai Yizhong Pharmaceutical Co., Ltd. was held on March 29, 2025, at the company's conference room [1]. - A total of 68 ordinary shareholders attended the meeting, holding 101,782,296 voting rights, which accounts for 49.2406% of the total voting rights of the company [1]. Voting Results - All proposed resolutions were passed during the meeting, with the voting results showing a high level of agreement among shareholders [2][3]. - For the first resolution, 101,611,261 votes (99.8319%) were in favor, with only 90,240 votes against and 80,795 abstentions [2]. - The second resolution also received 101,611,261 votes in favor (99.8319%), with similar opposition and abstention numbers [2]. - The third resolution had 101,599,561 votes in favor (99.8204%), with 101,940 votes against and 80,795 abstentions [2]. Legal Compliance - The meeting's procedures, including the convening and voting processes, were confirmed to comply with the Company Law and the company's articles of association, ensuring the legality and validity of the resolutions passed [1][3]. Legal Witness - The meeting was witnessed by lawyers Zhou Feng and Shen Guoxing, who confirmed that the meeting's procedures and results adhered to legal standards [3]. Conclusion - The board of directors of Shanghai Yizhong Pharmaceutical Co., Ltd. announced the successful completion of the shareholder meeting and the passing of all resolutions [4].